REGINfo: Orion - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- MAZOR ROBOTICS
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- POALIM
- SHUFERSAL
- SODASTREAM
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

OMXH 25 NEWS

FEEDS

My Google

Microsoft Live

My Yahoo

COMPANY SEARCH RESULT

$Orion: Click to view the issuer\'s details$

Last update : 03/04/2012 >View issuer details

2019.03.08 | 07:30 | Permanent Information Releases / General Company News

puce Darolutamide submitted for European marketing authorization - HTML (w)

2019.03.05 | 07:00 | Permanent Information Releases / General Company News

puce Darolutamide submitted for marketing authorization in Japan - HTML (w)

2019.03.04 | 11:00 | Permanent Information Releases / Notification of availability

puce Orion Group Financial Statement documents 2018 and Corporate Governance Statement published - HTML (w)

2019.03.01 | 18:10 | Share History / Voting Rights and Number of Shares

puce Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019 - HTML (w)

2019.02.27 | 06:00 | Permanent Information Releases / General Company News

puce The rolling submission to FDA for darolutamide in the U.S. completed - HTML (w)

2019.02.14 | 22:45 | Permanent Information Releases / General Company News

puce Orion's and Bayer's darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial - HTML (w)

2019.02.11 | 15:00 | Permanent Information Releases / General Company News

puce Orion and Propeller Health partner to bring new digital medicines to people with asthma and COPD - HTML (w)

2019.02.06 | 11:45 | Periodic information / Internal Control & Corporate Governance

puce The Board of Directors of Orion Corporation decided on an incentive plan for key persons - HTML (w)

2019.02.06 | 11:30 | Annual General Meeting / Preparatory Documents

puce Notice to the Annual General Meeting of Orion Corporation - HTML (w)

2019.02.06 | 11:00 | Permanent Information Releases / Sales and Revenues

puce Orion Group Financial Statement Release for 2018 - HTML (w)

2019.02.05 | 14:00 | Permanent Information Releases / General Company News

puce Orion and Bayer jointly present new data in prostate cancer from the Darolutamide ARAMIS -study - HTML (w)

2019.02.04 | 09:00 | Permanent Information Releases / General Company News

puce Orion intents to start an open label extension study to the REFALS phase 3 trial studying the effect of oral levosimendan in patients with ALS - HTML (w)

2019.01.23 | 12:30 | Permanent Information Releases / Notification of availability

puce Publishing of Orion Corporation's Financial Statement Release for 2018 on 6 February 2019 - HTML (w)

2019.01.09 | 11:40 | Permanent Information Releases / Appointments

puce Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation - HTML (w)

2019.01.04 | 08:00 | Permanent Information Releases / General Company News

puce Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 179